NHAS
Novo Holdings A/S Portfolio holdings
AUM $1.42B
1-Year Return
12.08%
This Quarter Return
-15.72%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$584M
AUM Growth
-$130M
(-18%)
Cap. Flow
-$8.05M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
80.9%
Holding
33
New
4
Increased
7
Reduced
2
Closed
4
Top Buys
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$24.6M |
| 2 |
Protagonist Therapeutics
PTGX
|
+$5.47M |
| 3 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
+$3.25M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$2.77M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
+$1.92M |
Top Sells
| 1 |
Glaukos
GKOS
|
+$22.6M |
| 2 |
Galapagos
GLPG
|
+$12.6M |
| 3 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
+$8.38M |
| 4 |
Merus
MRUS
|
+$7.25M |
| 5 |
Corvus Pharmaceuticals
CRVS
|
+$4.49M |
Sector Composition
| 1 | Healthcare | 73.42% |
| 2 | Technology | 10.28% |
| 3 | Communication Services | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
26
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.5M | 0.26% |
+35,900
| New | +$1.5M |
|
|
ZGNX
27
DELISTED
Zogenix, Inc.
ZGNX
| $1.43M | 0.24% |
+35,700
| New | +$1.43M |
|
28
Cogent Biosciences
COGT
$1.73B
| $682K | 0.12% |
118,360
| – | – |
|
|
29
Glaukos
GKOS
$4.64B
| – | – |
-300,000
| Closed | -$22.6M |
|
|
30
Galapagos
GLPG
$2.09B
| – | – |
-97,481
| Closed | -$12.6M |
|
|
31
Merus
MRUS
$5.13B
| – | – |
-495,016
| Closed | -$7.25M |
|
|
NBRV
32
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| – | – |
-13,786
| Closed | -$8.38M |
|